UK PureWick™ At-Home Pilot Study
- Sponsor
- Becton, Dickinson and Company
- Study ID
- NCT07555548
- Status
- Recruiting
Conditions
- Urinary Incontinence
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Treatment with the PureWick™ Urine Collection System External Catheter which is a non-invasive device designed to manage urinary incontinence — PROCEDUREAfter enrollment in the study, the preceding 4 weeks will be retrospectively assessed for subjects who encountered "problematic catheters" necessitating a minimum of five interventions within the past month, involving medical treatment and HCP consultation. Following a one-week familiarization period, a four-week prospective phase will commence during which subjects will utilize the PureWick™ Female External Catheter System.
Study Details
The UK PureWick™ At-Home Study is being carried out to see how well the PureWick™ Collection System works for women who use it at home instead of a traditional catheter. Traditional catheters are placed inside the body. The PureWick™ Collection System is different, it's placed outside the body . In this study, researchers want to find out: how effective the PureWick™ Collection System is in helping women manage urine collection at home, whether patients prefer using PureWick™ Collection System over the usual catheter, how it affects their sleep, and overall well-being.The PureWick™ Collection System is intended for the treatment of patients who leak urine (called urine incontinence). The PureWick™ Collection System is designed to help manage urine in female patients without needing to insert a urinary catheter into the body.
Key Dates
- First listed
- Apr 29, 2026
- Start date
- May 6, 2026
- Status verified
- Jul 2026
- Primary completion
- Nov 30, 2026
- Completion
- Jan 31, 2027
Study Design
- Enrollment
- 95 participants (estimated)
Primary Outcome Measure
Retrospective assessment of the clinical impact of problematic indwelling urinary catheters requiring intervention versus the clinical impact with the use of the PureWick™ System requiring intervention, documented during a prospective 4-week study period [ Time Frame: From enrollment to the end of treatment at 5 weeks ]
Central Contacts
- Winfried Huesmann+4915154403197
Related Studies
- Muscle Fiber Fragment Treatment for Urinary IncontinencePHASE1/PHASE2 · Recruiting · Wake Forest University · Winston-Salem, North Carolina
- Adjustable Continence Therapy (ACT) for the Treatment of Female SUIRecruiting · Uromedica · Denver, Colorado
- Sildenafil for Treatment of Urinary Incontinence in Patients With Spinal Cord InjuriesPHASE2 · Recruiting · The University of Texas Medical Branch, Galveston · Galveston, Texas
- Feasibility of Triggered Sacral Neuromodulation for Neurogenic BladderRecruiting · VA Office of Research and Development · Cleveland, Ohio